Glaukos CorporationGlaukos CorporationGlaukos Corporation

Glaukos Corporation

No trades
See on Supercharts
Market capitalization
‪4.84 B‬USD
−2.78USD
‪−134.66 M‬USD
‪314.71 M‬USD
‪48.01 M‬
Beta (1Y)
0.84

About Glaukos Corporation

CEO
Thomas William Burns
Headquarters
Aliso Viejo
Employees (FY)
907
Founded
1998
FIGI
BBG000WG2LQ1
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GKOS is 98.95 USD — it has increased by 2.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Glaukos Corporation stocks are traded under the ticker GKOS.
Glaukos Corporation is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
GKOS stock is 3.60% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is Glaukos Corporation there?
One year price forecast for Glaukos Corporation has a max estimate of 120.00 USD and a min estimate of 84.00 USD.
GKOS earnings for the last quarter are −0.50 USD per share, whereas the estimation was −0.55 USD resulting in a 9.12% surprise. The estimated earnings for the next quarter are −0.55 USD per share. See more details about Glaukos Corporation earnings.
Glaukos Corporation revenue for the last quarter amounts to ‪78.05 M‬ USD despite the estimated figure of ‪75.25 M‬ USD. In the next quarter revenue is expected to reach ‪81.00 M‬ USD.
Yes, you can track Glaukos Corporation financials in yearly and quarterly reports right on TradingView.
GKOS stock has fallen by 0.04% compared to the previous week, the month change is a 13.33% rise, over the last year Glaukos Corporation has showed a 99.54% increase.
GKOS net income for the last quarter is ‪−36.78 M‬ USD, while the quarter before that showed ‪−30.44 M‬ USD of net income which accounts for −20.81% change. Track more Glaukos Corporation financial stats to get the full picture.
Today Glaukos Corporation has the market capitalization of ‪4.84 B‬, it has increased by 12.46% over the last week.
No, GKOS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GKOS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Glaukos Corporation stock right from TradingView charts — choose your broker and connect to your account.
GKOS reached its all-time high on Apr 9, 2024 with the price of 102.33 USD, and its all-time low was 14.25 USD and was reached on Feb 8, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 907.00 employees. See our rating of the largest employees — is Glaukos Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Glaukos Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Glaukos Corporation stock shows the buy signal. See more of Glaukos Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Glaukos Corporation future price: according to them, GKOS price has a max estimate of 120.00 USD and a min estimate of 84.00 USD. Read a more detailed Glaukos Corporation forecast: see what analysts think of Glaukos Corporation and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Glaukos Corporation EBITDA is ‪−79.52 M‬ USD, and current EBITDA margin is −27.24%. See more stats in Glaukos Corporation financial statements.